Changes in cerebral connectivity and brain tissue pulsations with the antidepressant response to an equimolar mixture of oxygen and nitrous oxide: an MRI and ultrasound study.
Thomas Desmidt, Paul-Armand Dujardin, Frédéric Andersson, Bruno Brizard, Jean-Pierre Réméniéras, Valérie Gissot, Nicolas Arlicot, Laurent Barantin, Fabien Espitalier, Catherine Belzung, Arnaud Tanti, Gabriel Robert, Samuel Bulteau, Quentin Gallet, François Kazour, Sandrine Cognet, Vincent Camus, Wissam El-Hage, Pierre Poupin, Helmet T Karim
Molecular psychiatry September 1, 2023 DOI: 10.1038/s41380-023-02217-6 via PubMed
Summary
AI-generated from the abstractA single one-hour session of a 50:50 nitrous oxide/oxygen mixture (EMONO) rapidly alters functional connectivity in the default mode network and increases brain tissue pulsations in depressed women who respond to the treatment. Among 20 women with treatment-resistant depression, 45% showed at least a 50% reduction in depression scores one week after exposure. Responders exhibited decreased connectivity between the subgenual anterior cingulate cortex and the precuneus, and a larger early increase in brain tissue pulsations, which may enhance drug delivery. Non-responders and healthy controls showed different connectivity changes. The findings suggest potential cerebral mechanisms and markers for antidepressant response to nitrous oxide.
Study at a glance
| Characteristics | Observational cohort Peer reviewed |
|---|---|
| Sample size | 30 |
| Population | Women aged 25-50 with treatment-resistant major depressive episode or healthy controls |
| Intervention | Equimolar Mixture of Oxygen and Nitrous Oxide (EMONO) |
| Dose | 1-h single session of EMONO |
| Duration | 1-hour exposure, 1-week follow-up |
| Key finding | A single session of EMONO rapidly modifies functional connectivity in the subgenual ACC-precuneus and increases brain tissue pulsations, with larger early pulsation increases associated with antidepressant response. |
Abstract
Nitrous oxide (N2O) has recently emerged as a potential fast-acting antidepressant but the cerebral mechanisms involved in this effect remain speculative. We hypothesized that the antidepressant response to an Equimolar Mixture of Oxygen and Nitrous Oxide (EMONO) would be associated with changes in cerebral connectivity and brain tissue pulsations (BTP). Thirty participants (20 with a major depressive episode resistant to at least one antidepressant and 10 healthy controls-HC, aged 25-50, only females) were exposed to a 1-h single session of EMONO and followed for 1 week. We defined response as a reduction of at least 50% in the MADRS score 1 week after exposure. Cerebral connectivity of the Anterior Cingulate Cortex (ACC), using ROI-based resting state fMRI, and BTP, using ultrasound Tissue Pulsatility Imaging, were compared before and rapidly after exposure (as well as during exposure for BTP) among HC, non-responders and responders. We conducted analyses to compare group × time, group, and time effects. Nine (45%) depressed participants were considered responders and eleven (55%) non-responders. In responders, we observed a significant reduction in the connectivity of the subgenual ACC with the precuneus. Connectivity of the supracallosal ACC with the mid-cingulate also significantly decreased after exposure in HC and in non-responders. BTP significantly increased in the three groups between baseline and gas exposure, but the increase in BTP within the first 10 min was only significant in responders. We found that a single session of EMONO can rapidly modify the functional connectivity in the subgenual ACC-precuneus, nodes within the default mode network, in depressed participants responders to EMONO. In addition, larger increases in BTP, associated with a significant rise in cerebral blood flow, appear to promote the antidepressant response, possibly by facilitating optimal drug delivery to the brain. Our study identified potential cerebral mechanisms related to the antidepressant response of N2O, as well as potential markers for treatment response with this fast-acting antidepressant.